Clinical Trials

Breast Neoplasms

NCT06857747 2025-03-04

Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer.

40 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms

NCT04660929 2024-12-18

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Phase 1 Unknown

48 enrolled

Carcinoma, Ovarian Epithelial, Adenocarcinoma, Bile Duct Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Small Cell, Carcinoma, Ductal, Small Cell Lung Carcinoma, Inflammatory Breast Neoplasms

NCT06678230 2024-11-07

Clinical Trial of Eribulin in Combination with Anrotinib for HER-2 Negative Locally Advanced or Metastatic Breast Cancer

40 enrolled

Breast Neoplasms

NCT06347354 2024-08-27

FLUO

10 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

260 enrolled

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT06311695 2024-06-24

CESM

263 enrolled

Breast Neoplasms

NCT05371847 2024-05-01

UPLIFT-BC

150 enrolled

Breast Neoplasms

NCT06385665 2024-04-26

The Effect of Appropriate Family Companionship on the Physical and Mental Health of Patients With Advanced Breast Cancer

304 enrolled

Breast Neoplasms

NCT06334380 2024-04-25

VR-PREP

30 enrolled

Frailty, Breast Neoplasms

NCT05982626 2024-04-24

Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer

10 enrolled

BreastGastrointestinalGynecologic

Breast Neoplasms

NCT05989724 2024-04-24

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Phase 1 Unknown

150 enrolled

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05939310 2024-04-19

MARGIN-2

70 enrolled

Breast Neoplasms

NCT06376357 2024-04-19

The Effect of Foot Massage With Roles on Cancer Patients

54 enrolled

Breast Neoplasms

NCT05084625 2024-04-17

PACED-digitized Support During Adjuvant Endocrine Therapy

300 enrolled

Treatment Adherence and Compliance, Breast Neoplasms

NCT05925257 2024-04-17

Digital Health Intervention to Improve Health Care and Outcomes for Breast Cancer Patients

410 enrolled

Breast Neoplasms

NCT04418856 2024-04-16

The Effects of Light Therapy to Treat Cancer-related Side Effects

240 enrolled

Breast Neoplasms, Depression, Fatigue, Parasomnias, Cognitive Dysfunction

NCT05659056 2024-04-16

Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer

65 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT05919212 2024-04-15

DIAMOND

22 enrolled

Breast Neoplasms

NCT03639948 2024-04-11

NeoPACT

120 enrolled 12 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05467111 2024-04-11

CardioProtEx

40 enrolled

Breast Neoplasms, Motor Activity, Cardiotoxicity

NCT06360809 2024-04-11

PEP_BC

76 enrolled

Phase EARLY_PHASE1 Unknown

Breast Neoplasms, Motor Activity

NCT06361264 2024-04-11

Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide

20 enrolled

Breast Neoplasms

NCT04469127 2024-04-10

Heroine01

Phase 1/2 Unknown

100 enrolled

Breast Neoplasms

NCT04391543 2024-04-09

BIOpsychosocial Approach of the CAncer-RElated FAtigue (BIOCARE FActory)

86 enrolled

Breast Neoplasms

NCT06341842 2024-04-02

PROTECT

316 enrolled